StockClub
ERNAErnexa Therapeutics Inc.$ --
Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc.

ERNA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-4M USD
YoY -29.9%
Net Income
-6M USD
YoY +32.9%
EPS
-6.95$
YoY -85.3%

Revenue

$0
FY2024 Q2$94,000
$94,000
Q2
FY2024 Q3$581,000
$581,000
Q3
FY2024 Q4$582,000
$582,000
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-5.5M
FY2024 Q2$-12.2M
$-12.2M
Q2
FY2024 Q3$-38.8M
$-38.8M
Q3
FY2024 Q4$-44.5M
$-44.5M
Q4
FY2025 Q1$-8.2M
$-8.2M
Q1
FY2025 Q2$-11.3M
$-11.3M
Q2
FY2025 Q3$-12.6M
$-12.6M
Q3
FY2025 Q4$-14.1M
$-14.1M
Q4
FY2026 Q1$-5.5M
$-5.5M
Q1
Actual
+$2.7M (+32.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$0
Est:$25.6M
FY2020MISS
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$68,000
FY2023
$68,000
FY2024IN-LINE
Actual:$582,000
Est:$582,000
FY2024IN-LINE
$582,000
FY2025MISS
Actual:$0
Est:$32.8M
FY2025MISS
$0

Analyst Estimates

No forecast data